A new CRF antagonist (cyclo(30/33) that, when injected into the CSF at low doses (1-10ug), results in antagonistic action against CRF and stress-related alterations of gastrointestinal motor function, without an intrinsic effect in these in vivo systems. MW: 3563.2 Da. Purity >98 % purified